HCV Coinfection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HCV Coinfection trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07429864

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

HDV is an RNA virus that infects only in the presence of HBV, affecting about 13% of HBsAg carriers. In Italy, prevalence ranges from 3.2% to 9.3%. It increases…

Italy20 participantsStarted 2025-09-24

All recent trials (100 shown)

CompletedNot Applicable

NCT00004850

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

This study will evaluate hepatitis C virus (HCV) infection in blood donors who test positive for antibodies to this virus. Most HCV-infected people do not becom…

United States805 participantsStarted 1991-03-15

CompletedPhase 2

NCT06144086

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

This is a phase 2 trial of foscenvivint in liver cirrhosis patients caused by HIV/HCV co-infection with hemophilia to evaluate the efficacy, safety and pharmaco…

Japan5 participantsStarted 2024-05-08

Treatment: Foscenvivint

HCV Coinfection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

All recent trials (100 shown)

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

All recent trials (100 shown)

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Supporting Treatment Outcomes Among PWID

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Zepatier in Patients with Substance Use

Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

deLIVER: Direct Acting Antiviral Effects on the Liver

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Ad…

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C…

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures